U.S. Treasury’s FinCEN Warns of Medical Scams Exploiting COVID-19

The US Financial Crimes Enforcement Network (FinCEN) is
warning companies and financial institutions of a sudden rise in medical scams related
to the COVID-19 pandemic, in the first series of alerts regarding this issue.

The U.S. Treasury and FinCEN are acting on information from
a few sources, including public reports, Bank Secrecy Act data, and law
enforcement partners. Depending on the affected industry, the type of scam
differs in scope and methods.

The biggest problem right now comes from scams that tout
COVID-19-related cures, tests, vaccines, and associated services being offered
to the public, which actually don’t exist.

“Examples of fraudulent medical services include claims
related to purported vaccines or cures for COVID-19, claims related to products
that purportedly disinfect homes or buildings, and the distribution of
fraudulent or unauthorized at-home COVID-19 tests,” states the advisory.
“Some of these scams may be perpetrated by illicit actors who recently formed unregistered
or unlicensed medical supply companies.”

Another issue is directly related to disruptions in the
demand and shipping of certain goods, with criminals looking to defraud consumers
and companies by not delivering the ordered merchandise. Affected products
include test kits, masks, drugs and other goods.

Finally, FinCEN and the Department of Justice (DOJ) have
received numerous reports of people and companies either hoarding products or price
gouging. Both of these practices are illegal under the Defense Production Act.

FinCEN is asking all financial institutions to use the
details in the advisory and indicate a connection between the suspicious
activity and other recent activities. Furthermore, they have to report any
information regarding reporting COVID-19-related crimes and reminds financial
institutions of certain BSA obligations.

Leave a Reply

Your email address will not be published.

Scroll to top